Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.

Disease markers - 1 Jan 2017

Štrbac Danijela, Goričar Katja, Dolžan Vita, Kovač Viljem

Abstract excerpt

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare disease with a relatively short overall survival (OS). Metalloproteinases (MMPs) have a vast biological effect on tumor progression, invasion, metastasis formation, and apoptosis. MMP expression was previously associated with survival in MPM. Our aim was to evaluate if genetic variability of MMP genes could also serve as a prognostic biomarker in MPM....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to Heterozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lung Neoplasms

Share to Matrix Metalloproteinases

Share to Mesothelioma

Share to Mesothelioma, Malignant

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 29138529
DOI: 10.1155/2017/8069529
PMCID: PMC5613362

Genes

MMP9
MMP14
MMP2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.PMID 29138529Read ↗

Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review.Semantic proximity Read ↗

Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesotheliomaSemantic proximity Read ↗

Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis.Semantic proximity Read ↗

MMP2 gene polymorphism and tumor susceptibility studySemantic proximity Read ↗

Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Semantic proximity Read ↗

Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour TargetSemantic proximity Read ↗

Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.Semantic proximity Read ↗

Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients.Semantic proximity Read ↗

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival.Semantic proximity Read ↗

Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population.Semantic proximity Read ↗

The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors.Semantic proximity Read ↗

Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.